Dozo Biotech
Dozo Biotech
  • Home
  • About Us
  • Innovation
  • Oncology
  • CNS
  • Metabolism
  • Inflammation
  • Partnering
  • Contact Us
  • More
    • Home
    • About Us
    • Innovation
    • Oncology
    • CNS
    • Metabolism
    • Inflammation
    • Partnering
    • Contact Us
  • Home
  • About Us
  • Innovation
  • Oncology
  • CNS
  • Metabolism
  • Inflammation
  • Partnering
  • Contact Us

MASH and DIABETES

Precision Medicine

 We are acting on our purpose to defeat serious chronic diseases by expanding our commitment in areas of high unmet need, including metabolic dysfunction-associated steatohepatitis (MASH).  This is a disease that impacts a growing number of people worldwide, and we welcome you to learn more about its causes, symptoms, and how to improve liver health, while also discovering our research and development efforts to help address the unmet medical need in this disease area. 


 We are committed to driving change to improve treatment options for people living with type 2 and Type 1 diabetes – from more effective medicines to  take care of their diabetic  complications  that make management simpler and more convenient. 

Copyright © 2025 Dozo Biotech - All Rights Reserved.

Powered by

  • Contact Us

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept